Exchange: NASDAQ·Updated 04:27 AM EDT
CERT logo

CERT Certara Inc

$9.30
$0.17
(1.86%)
Pre-Market
Prev Close $9.13
EarningsNov 5
Mkt Cap$1.39B
Vol19.00

About CERT

Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017 and is headquartered in Radnor, PA.
50

Neutral Sentiment

How do you feel about CERT?

Advertisement|Remove ads.